Shree Pacetronix (SHREEPAC) | Financial Analysis & Statements
Shree Pacetronix Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
53.4M
Gross Profit
36.4M
68.11%
Operating Income
9.8M
18.43%
Net Income
6.6M
12.44%
EPS (Diluted)
₹1.85
Balance Sheet Metrics
Total Assets
230.5M
Total Liabilities
92.6M
Shareholders Equity
137.8M
Debt to Equity
0.67
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Shree Pacetronix Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 168.0M | 220.4M | 202.6M | 92.3M | 75.6M |
| Cost of Goods Sold | 65.8M | 82.0M | 75.4M | 36.1M | 30.3M |
| Gross Profit | 102.2M | 138.4M | 127.2M | 56.2M | 45.3M |
| Gross Margin % | 60.8% | 62.8% | 62.8% | 60.9% | 59.9% |
| Operating Expenses | |||||
| Research & Development | 4.4M | 6.9M | 6.7M | 2.3M | 2.3M |
| Selling, General & Administrative | 23.7M | 26.0M | 23.1M | 9.8M | 9.3M |
| Other Operating Expenses | 2.0M | 4.3M | 4.3M | 1.8M | 1.4M |
| Total Operating Expenses | 30.0M | 37.2M | 34.1M | 13.9M | 13.1M |
| Operating Income | 15.3M | 49.3M | 49.9M | 12.8M | 5.8M |
| Operating Margin % | 9.1% | 22.4% | 24.6% | 13.9% | 7.7% |
| Non-Operating Items | |||||
| Interest Income | 676.6K | 668.1K | 700.8K | 451.8K | 305.9K |
| Interest Expense | 5.8M | 3.6M | 2.5M | 2.8M | 3.3M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 10.4M | 46.2M | 46.2M | 10.6M | 1.3M |
| Income Tax | 2.9M | 12.6M | 13.6M | 2.8M | 789.0K |
| Effective Tax Rate % | 28.1% | 27.4% | 29.4% | 26.4% | 59.8% |
| Net Income | 7.5M | 33.6M | 32.6M | 7.8M | 529.9K |
| Net Margin % | 4.5% | 15.2% | 16.1% | 8.5% | 0.7% |
| Key Metrics | |||||
| EBITDA | 24.3M | 59.4M | 56.6M | 18.3M | 11.2M |
| EPS (Basic) | ₹2.08 | ₹9.33 | ₹9.06 | ₹2.17 | ₹0.15 |
| EPS (Diluted) | ₹2.08 | ₹9.33 | ₹9.06 | ₹2.17 | ₹0.15 |
| Basic Shares Outstanding | 3599400 | 3599400 | 3599400 | 3599400 | 3599400 |
| Diluted Shares Outstanding | 3599400 | 3599400 | 3599400 | 3599400 | 3599400 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Shree Pacetronix Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.8M | 1.1M | 712.5K | 8.9M | 7.7M |
| Short-term Investments | 7.1M | 6.9M | 7.7M | 5.4M | 569.0K |
| Accounts Receivable | 66.3M | 46.6M | 47.1M | 32.3M | 30.2M |
| Inventory | 70.3M | 57.4M | 29.8M | 16.6M | 19.6M |
| Other Current Assets | 1 | -1 | -1 | -1 | 3.7M |
| Total Current Assets | 171.9M | 150.7M | 108.1M | 71.7M | 61.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 245.4K | 245.4K | 245.4K | 245.4K | 245.4K |
| Goodwill | 835.7K | 840.0K | 844.2K | 893.7K | 900.1K |
| Intangible Assets | 835.7K | 840.0K | 844.2K | 893.7K | 900.1K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 58.6M | 66.7M | 57.3M | 50.1M | 48.0M |
| Total Assets | 230.5M | 217.5M | 165.4M | 121.8M | 109.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 8.7M | 2.5M | 6.1M | 1.5M | 3.5M |
| Short-term Debt | 47.1M | 37.5M | 18.3M | 24.5M | 25.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 15.9M | 14.7M | 17.1M | 12.5M | -1 |
| Total Current Liabilities | 88.7M | 81.3M | 64.7M | 51.4M | 46.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.6M | 5.4M | 3.6M | 5.9M | 6.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1 | - | - | - | - |
| Total Non-Current Liabilities | 4.0M | 5.8M | 3.9M | 6.2M | 7.2M |
| Total Liabilities | 92.6M | 87.1M | 68.7M | 57.6M | 53.5M |
| Equity | |||||
| Common Stock | 36.0M | 36.0M | 36.0M | 36.0M | 36.0M |
| Retained Earnings | 94.5M | 87.0M | 53.5M | 20.9M | 13.1M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 137.8M | 130.3M | 96.7M | 64.1M | 56.3M |
| Key Metrics | |||||
| Total Debt | 50.7M | 43.0M | 21.9M | 30.4M | 32.0M |
| Working Capital | 83.2M | 69.4M | 43.3M | 20.3M | 15.5M |
Balance Sheet Composition
Shree Pacetronix Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 104.3K | 46.2M | 46.2M | 10.6M | 1.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -180.8K | -43.0M | -42.4M | -3.3M | 4.1M |
| Operating Cash Flow | -25.0K | 6.2M | 5.5M | 9.7M | 8.6M |
| Investing Activities | |||||
| Capital Expenditures | -71.7K | -13.4M | -12.1M | -3.4M | -5.6M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -16.7K | -4.8M | -441.4K | -3.5M | -119.1K |
| Investment Sales | 49.6K | 803.0K | - | - | - |
| Investing Cash Flow | -10.9K | -16.6M | -14.8M | -12.3M | -5.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 1.9M | - | - | 719.8K |
| Debt Repayment | -1.8M | - | -8.5M | -1.6M | -314.3K |
| Financing Cash Flow | -1.7M | 21.1M | -14.8M | -2.2M | 91.2K |
| Free Cash Flow | -72.5K | -14.1M | 4.6M | 13.5M | 3.3M |
| Net Change in Cash | -1.8M | 10.7M | -24.1M | -4.8M | 3.1M |
Cash Flow Trend
Shree Pacetronix Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.75
Price to Book
3.24
Price to Sales
2.59
PEG Ratio
-0.14
Profitability Ratios
Profit Margin
12.10%
Operating Margin
6.16%
Return on Equity
5.44%
Return on Assets
3.25%
Financial Health
Current Ratio
2.10
Debt to Equity
32.04
Beta
-0.98
Per Share Data
EPS (TTM)
₹6.84
Book Value per Share
₹43.78
Revenue per Share
₹56.96
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SHREEPAC | 532.1M | 20.75 | 3.24 | 5.44% | 12.10% | 32.04 |
| Poly Medicure | 151.0B | 43.53 | 5.17 | 12.24% | 19.51% | 8.17 |
| Dr Agarwal's Health | 138.9B | 109.80 | 7.17 | 4.33% | 6.38% | 48.68 |
| Tarsons Products | 11.0B | 55.45 | 1.81 | 4.72% | 4.91% | 63.18 |
| Laxmi Dental | 10.4B | 44.95 | 4.43 | 15.22% | 8.76% | 3.88 |
| Prevest Denpro | 5.4B | 27.33 | 4.69 | 17.20% | 27.78% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.




